This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says RE
Transcript : West Pharmaceutical Services, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:00 AM
Pacific Edge's Chair to Retire; Shares Fall 3% MT
West Pharmaceutical Services Inc Files a Definitive Proxy Statement CI
Transcript : West Pharmaceutical Services, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 01:05 PM
West Pharmaceutical Services Insider Sold Shares Worth $292,436, According to a Recent SEC Filing MT
Accenture: acquisition of Australian company The Lumery CF
West Pharmaceutical Services Inc Receives a Shareholder Proposal from John Chevedden CI
West Pharmaceutical Services Insider Sold Shares Worth $724,061, According to a Recent SEC Filing MT
West Pharmaceutical Services Insider Sold Shares Worth $2,559,380, According to a Recent SEC Filing MT
West Pharmaceutical Services Maintains Quarterly Dividend at $0.20 per Share; Payable May 1 to Holders of Record on April 24 MT
West Pharmaceutical Services, Inc. Announces Second Quarter 2024 Dividend, Payable on May 1, 2024 CI
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating MT
Forget about rate cuts... Our Logo
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia... Our Logo
S&P 500 Hits Record High as Traders Parse Economic Data MT
S&P 500 Hits Record High as Traders Parse Economic Data MT
Sector Update: Health Care Stocks Higher Late Afternoon MT
Top Midday Decliners MT
Wall Street ends higher as retail sales slump feeds hopes for rate cuts RE
Equity Markets Rise Intraday as Traders Parse Economic Data, Earnings MT
Sector Update: Health Care Stocks Higher Thursday Afternoon MT
Nasdaq Lags US Equity Indexes' Move Higher as Investors Brace for Producer Price Inflation Data After Supportive Retail Sales MT
US Benchmark Indexes Mixed as Investors Assess Retail Sales, Jobless Claims MT
Chart West Pharmaceutical Services, Inc.
More charts
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
390.2 USD
Average target price
392.8 USD
Spread / Average Target
+0.67%
Consensus
  1. Stock Market
  2. Equities
  3. WST Stock
  4. News West Pharmaceutical Services, Inc.
  5. West Pharmaceutical Services Maintains Quarterly Dividend at $0.20 per Share; Payable May 1 to Holders of Record on April 24